補(bǔ)體因子I(CFI)多克隆抗體
Polyclonal Antibody to Complement Factor I (CFI)
CF-I; C3b-INA; FI; IF; KAF; Factor I; Konglutinogen-Activating Factor; C3b-Inactivator; C3B/C4B inactivator
- 編號PAB978Hu02
- 物種Homo sapiens (Human，人)相同的名稱，不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型IgG
- 純化方式抗原特異性親和純化
- 標(biāo)記物無標(biāo)記物
- 免疫原RPB978Hu02-補(bǔ)體因子I(CFI)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性狀液體
- 濃度0.5mg/ml
- 且適物種Sus scrofa; Porcine (Pig，豬)
- 應(yīng)用WB; IHC; ICC; IP.
如果抗體需用于流式細(xì)胞術(shù)，請參見流式抗體。 - 下載英文說明書 中文說明書
- 規(guī)格20μl100μl200μl1ml10ml
- 價格¥ 598¥ 1394¥ 1992¥ 4980¥ 19920
- 欲了解實際交易價格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
DAB staining on IHC-P; Samples: Human Cardiac Muscle Tissue; Primary Ab: 20μg/ml Rabbit Anti-Human CFI Antibody Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody (Catalog: SAA544Rb19)
DAB staining on IHC-P;
Samples: Human Kidney Tissue;
Primary Ab: 20μg/ml Rabbit Anti-Human CFI Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
DAB staining on IHC-P;
Samples: Human Cerebrum Tissue;
Primary Ab: 20μg/ml Rabbit Anti-Human CFI Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
Figure. Western Blot; Sample: Recombinant CFI, Human.
Figure. Western Blot; Sample: Porcine Kidney Tissue.
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
特異性
該抗體是針對CFI的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實驗中能識別CFI。
用法
Western blotting: 0.01-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPB978Hu02 | 補(bǔ)體因子I(CFI)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB978Hu01 | 補(bǔ)體因子I(CFI)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB978Hu01 | 補(bǔ)體因子I(CFI)多克隆抗體 | WB |
| PAB978Hu02 | 補(bǔ)體因子I(CFI)多克隆抗體 | WB; IHC; ICC; IP. |
| MAB978Hu22 | 補(bǔ)體因子I(CFI)單克隆抗體 | WB; IHC; ICC; IP. |
| WEB978Hu | 補(bǔ)體因子I(CFI)檢測試劑盒(酶聯(lián)免疫吸附試驗法,寬范圍) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SEB978Hu | 補(bǔ)體因子I(CFI)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB978Hu | 補(bǔ)體因子I(CFI)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| J Thromb Haemost | A case report of thrombotic microangiopathy without renal involvement carrying two novel mutations in complement-regulator genes[PubMed: 26613809] |
| Pediatr Int | Atypical hemolytic uremic syndrome: Korean pediatric series[PubMed: 25443527] |
| United States Patent Application? | NOVEL ASSAY[y2016:139118] |
| Researchgate | Compliment factor i bioassay[US20170285024] |
| PLoS One | A monoclonal antibody targeting amyloid β (Aβ) restores complement factor I bioactivity: Potential implications in age-related macular degeneration and?…[Pubmed:29782502] |
| JOURNAL OF CELLULAR AND MOLECULAR MEDICINE | The importance of sialic acid, pH and ion concentration on the interaction of uromodulin and complement factor H[33788378] |